GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Sloan Ratio %

Shan Dong Kexing Bioproducts Co (SHSE:688136) Sloan Ratio % : -1.25% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Shan Dong Kexing Bioproducts Co's Sloan Ratio for the quarter that ended in Mar. 2024 was -1.25%.

As of Mar. 2024, Shan Dong Kexing Bioproducts Co has a Sloan Ratio of -1.25%, indicating the company is in the safe zone and there is no funny business with accruals.


Shan Dong Kexing Bioproducts Co Sloan Ratio % Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Sloan Ratio % Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial 17.64 9.75 17.50 11.91 1.75

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.45 5.63 9.82 1.75 -1.25

Competitive Comparison of Shan Dong Kexing Bioproducts Co's Sloan Ratio %

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co's Sloan Ratio % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Sloan Ratio % falls into.



Shan Dong Kexing Bioproducts Co Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Shan Dong Kexing Bioproducts Co's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-190.29--87.135
--156.247)/3031.093
=1.75%

Shan Dong Kexing Bioproducts Co's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-169.121--46.762
--84.177)/3063.871
=-1.25%

Shan Dong Kexing Bioproducts Co's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -38.795 (Jun. 2023 ) + -6.753 (Sep. 2023 ) + -135.976 (Dec. 2023 ) + 12.403 (Mar. 2024 ) = ¥-169 Mil.
Shan Dong Kexing Bioproducts Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was -40.542 (Jun. 2023 ) + 12.645 (Sep. 2023 ) + -12.641 (Dec. 2023 ) + -6.224 (Mar. 2024 ) = ¥-47 Mil.
Shan Dong Kexing Bioproducts Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 16.059 (Jun. 2023 ) + -148.903 (Sep. 2023 ) + 272.751 (Dec. 2023 ) + -224.084 (Mar. 2024 ) = ¥-84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shan Dong Kexing Bioproducts Co  (SHSE:688136) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Shan Dong Kexing Bioproducts Co has a Sloan Ratio of -1.25%, indicating the company is in the safe zone and there is no funny business with accruals.


Shan Dong Kexing Bioproducts Co Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Traded in Other Exchanges
N/A
Address
No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Executives
Wang Xiao Qin Directors, senior managers
Cui Ning Directors, senior managers
Ma Hong Jie senior management
Shao Ke senior management
Deng Xue Qin Director
Zhao Yan Qing Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines